| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 01/10/2013 | US20130012720 Total synthesis of salinosporamide a and analogs thereof |
| 01/10/2013 | US20130012496 Benzazepine compound |
| 01/10/2013 | US20130012493 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012492 Fused heterocyclic compounds as ion channel modulators |
| 01/10/2013 | CA2841229A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
| 01/10/2013 | CA2841226A1 Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
| 01/10/2013 | CA2841220A1 Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring |
| 01/10/2013 | CA2841214A1 Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
| 01/10/2013 | CA2838234A1 Oxazepines as ion channel modulators |
| 01/10/2013 | CA2838223A1 Fused benzoxazepinones as ion channel modulators |
| 01/09/2013 | EP2543667A1 2-aminopyridine analogs as glucokinase activators |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | EP2542537A1 Novel compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (ror gamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 01/09/2013 | EP2542536A1 Morpholino substituted urea derivatives as mtor inhibitors |
| 01/09/2013 | EP2542225A2 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect. |
| 01/09/2013 | CN1876657B Stabilization of macrolides |
| 01/09/2013 | CN102869665A Benzazepine compound |
| 01/09/2013 | CN102863459A Preparation method of trewiasine |
| 01/09/2013 | CN102863458A Purification method of tacrolimus crude products |
| 01/09/2013 | CN101711243B 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 01/08/2013 | US8349829 [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials |
| 01/08/2013 | CA2628921C Process for the preparation of delmopinol and derivatives thereof |
| 01/03/2013 | WO2013003383A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
| 01/03/2013 | WO2013001310A1 Macrocyclic compounds and their use as cdk8 inhibitors |
| 01/03/2013 | US20130006350 Drug-delivery endovascular stent and method for treating restenosis |
| 01/03/2013 | US20130005706 Fused heterocyclic compounds as ion channel modulators |
| 01/03/2013 | US20130005701 Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130004576 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect |
| 01/03/2013 | CA2840060A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/02/2013 | EP2539347A2 Trimethoxyphenyl inhibitors of tyrosine kinase |
| 01/02/2013 | EP2539338A1 Novel microbicides |
| 01/02/2013 | EP2539322A1 Inhibitors of beta-secretase |
| 01/02/2013 | CN102850378A Preparation method of fenspiride |
| 01/02/2013 | CN102850377A Preparation method of levofloxacin hydrochloride |
| 01/02/2013 | CN102850376A One-step synthesizing method of levofloxacin and ofloxacin |
| 01/02/2013 | CN102850375A Polysubstituted pyridine[4,5-d]oxazine compounds and preparation method |
| 01/02/2013 | CN102850336A Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 01/02/2013 | CN101944571B Single-layer organic el device |
| 01/02/2013 | CN101189222B Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 01/01/2013 | US8343980 Quinazoles useful as modulators of ion channels |
| 01/01/2013 | US8343913 Hsp90, buffering and drug resistance |
| 12/27/2012 | WO2012177770A1 Bipartite inhibitors of bacterial rna polymerase |
| 12/27/2012 | WO2012176856A2 Pesticide |
| 12/27/2012 | WO2012175702A1 Rimfampicin analogue useful for infection imaging |
| 12/27/2012 | WO2012145255A3 Diazonamide analogs |
| 12/27/2012 | WO2012089349A3 Novel polyketide compounds and methods of making same |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120329791 Substituted Imidazopyridinyl-Aminopyridine Compounds |
| 12/27/2012 | US20120329779 Method of Treating Mixed Lineage Leukemia Gene-Rearranged Acute Lymphoblastic Leukemias |
| 12/27/2012 | US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments |
| 12/27/2012 | US20120328691 Anilinopiperazine derivatives and methods of use thereof |
| 12/27/2012 | US20120328569 Inhibitors of hepatitis c virus ns5b polymerase |
| 12/27/2012 | US20120328530 Toluidine blue derivatives as photosensitising compounds |
| 12/26/2012 | EP2537845A1 6H-dibenzo[B,E]oxepine derived nonsteroidal mineralocorticoid receptor antagonists |
| 12/26/2012 | EP2536734A1 Forms of rifaximin and uses thereof |
| 12/26/2012 | EP2536710A2 Piperidine derivatives |
| 12/26/2012 | EP2536279A1 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate |
| 12/26/2012 | CN1826333B Diamine derivatives |
| 12/20/2012 | WO2012172093A1 Dihydroindolizine derivate as metabotropic glutamate receptor modulators |
| 12/20/2012 | WO2012171863A1 New selective ccr2 antagonists |
| 12/20/2012 | US20120322791 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS |
| 12/20/2012 | US20120322789 Organic compounds |
| 12/20/2012 | US20120322788 Compouds |
| 12/19/2012 | EP2534158A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity |
| 12/19/2012 | EP2534154A1 Macrocycles as factor xia inhibitors |
| 12/19/2012 | EP2534152A1 Macrocycles as factor xia inhibitors |
| 12/19/2012 | CN102834513A Antiviral therapeutic agents |
| 12/19/2012 | CN102834400A 2,5-substituted oxazolopyrimidine derivatives |
| 12/19/2012 | CN102834399A Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
| 12/19/2012 | CN102834398A Forms of rifaximin and uses thereof |
| 12/19/2012 | CN102834397A Macrocycles as factor xia inhibitors |
| 12/19/2012 | CN102834384A Oxazine derivative |
| 12/19/2012 | CN102827187A Fluoroquinolone acetal isoniazone, and preparation method and application thereof |
| 12/19/2012 | CN102827186A Pyridino five-membered heterocyclic derivative as well as preparation method and applications thereof |
| 12/18/2012 | US8334309 Heterocyclic indazole derivatives |
| 12/13/2012 | WO2012170867A1 Novel compounds as modulators of gpr-119 |
| 12/13/2012 | WO2012143080A3 Materials for organic electroluminescent devices |
| 12/13/2012 | US20120316334 Forms of rifaximin and uses thereof |
| 12/13/2012 | US20120316228 Oral antimicrobial pharmaceutical compositions |
| 12/13/2012 | US20120316184 Novel microbicides |
| 12/13/2012 | US20120316162 Piperidine and piperazine derivatives |
| 12/13/2012 | US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments |
| 12/13/2012 | US20120315661 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings |
| 12/13/2012 | US20120313083 6,12-dinaphthylchrysene derivative and organic light-emitting device using the derivative |
| 12/13/2012 | CA2836487A1 Novel compounds as modulators of gpr-119 |
| 12/12/2012 | EP2532657A2 Compounds and methods of use |
| 12/12/2012 | EP2531503A1 Gamma secretase modulaters |
| 12/12/2012 | EP2531197A1 Solid state forms of macrocyclic kinase inhibitors |
| 12/12/2012 | CN102822175A 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors |
| 12/12/2012 | CN102816175A Heterocyclic and pyridone type compound, intermediate, preparation method and application thereof |
| 12/12/2012 | CN102816170A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 12/12/2012 | CN102816127A Double-terminal group phthalonitrile-benzoxazine resin intermediate and its synthesis method |
| 12/12/2012 | CN102816119A 6,12-dinaphthylchrysene derivative and organic light-emitting device using the derivative |
| 12/12/2012 | CN101679401B 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors |
| 12/12/2012 | CN101479271B Long wavelength shifted benzotriazole uv-absorbers and their use |
| 12/12/2012 | CN101415716B Condensed imidazole derivatives as aldosterone synthase inhibitors |
| 12/11/2012 | US8329908 Dual action antibiotics |
| 12/11/2012 | US8329713 Fused ring heterocycles as potassium channel modulators |